Each one in plain English, with the numbers worked through for a shareholder.
20 Sept 2022capital raising announcement● Neutral
Amended re-release of the 19 September update: the $9M placement (~333.7M shares at $0.027) has settled, and Newcrest's $1M top-up is due 23 September, taking cash to about $13M. The $3M share purchase plan is due to open 23 September.
What it means for a shareholder
334m new shares at $0.027 to raise about $9.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
The $9M placement funds were received, with Newcrest's $1M due 23 September; Antipa expects about $13M cash afterwards. The $3M share purchase plan (up to $30,000 each, same price) is anticipated to run 23 September to 10 October.
Newcrest exercised its right to hold 9.9%, taking about 36.7M extra shares at $0.027 for ~$1.0M, lifting the placement to ~$10M. It also intends to top up again after the $3M share purchase plan.
Beaver Creek Precious Metals Summit presentation, September 2022, on the Minyari Dome stand-alone gold project. Repeats the 31 August Scoping Study; visible text is disclaimers only, with no new figures.
Antipa raised about $9M via a placement of ~333.7M shares at $0.027, plus a planned $3M share purchase plan; each two shares carry a free $0.04 option expiring in one year. Funds go to Minyari Dome drilling and the Pre-Feasibility Study. Dilutive to existing holders.
What it means for a shareholder
334m new shares at $0.027 to raise about $9.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
ASX paused trading in Antipa shares pending a further announcement. The reason is not stated; it was followed by the capital raising announced on 12 September.
Antipa expects to hold its AGM on 11 November 2022, with director nominations closing 22 September 2022. Notice of Meeting to follow in October. Administrative notice only.
Presentation of the 31 August Minyari Dome Scoping Study (stand-alone gold mining and processing, 100% owned). Repeats the already-released study; the visible text is disclaimers only, with no new figures.
Notice of an investor conference call on 1 September 2022 to discuss the Minyari Dome Scoping Study. Administrative announcement only; no new results or figures.
Scoping Study on a stand-alone Minyari Dome gold operation completed, building on the 1.8Moz resource of May 2022. It is a ±35% accuracy study; about A$275M pre-production funding may be needed, with no certainty it can be raised and possible dilution. Key economics are not visible in the text.
Diggers and Dealers conference presentation, August 2022; visible text is the title, a tagline about a Tier 1 gold-copper-silver-cobalt province, and disclaimers. No new results or figures visible.
June 2022 quarter: cash about $7.9m (including $1.4m held for farm-in parties), down from $11.9m at December. Recaps the Minyari resource, Citadel dilution, and the Scoping Study (Snowden Optiro) due Q3 CY22. All IGO assays now released.
The Citadel 2022 budget was cut from $10m to $6-8m. Antipa elected to dilute, receiving a refund of about $0.5m and making no further contributions; its interest is expected to fall from 35% to about 31.1-32.0%. Management says capital is being directed to Minyari.
Final 6,440m of Minyari greenfield assays returned gold at Minyari North (28m at 0.5 g/t) and GP01 (7m at 1.5 g/t), and four soil targets were identified. Follow-up drilling has begun. The Scoping Study is now expected to finish this quarter, ahead of the Q3 schedule.
Final Citadel 2021 results: Calibre hole intersected 14.4m at 1.02 g/t gold, and mineralisation extended up to 100m west and 150m below the southern resource (2.1Moz). Magnum North hit gold-copper 800m north. Rio-operated 2022 drilling of 8,000-11,000m planned; resource update possible.
IGO-funded Paterson 2021 work identified seven high-priority anomalies (three air core, four soil), the best being Ricochet (21m at 0.13 g/t gold). 2022 plans include diamond drilling of Havieron look-alike targets; $355,000 of WA EIS grants awarded. Early-stage results; this completes the pending Paterson assays.
Newcrest will take over management of the Wilki farm-in from 1 July 2022, after completing its $6m initial commitment in November 2021. It is now proceeding with Stage 1 ($10m by March 2025 for 51%), with withdrawal rights; no interest earned yet.
Minyari-WACA resource rises 250% to 1.8Moz gold (from 723koz), with 64,300t copper, at 1.6 g/t, of which 1.0Moz is Indicated. A Scoping Study has started, due Q3 CY2022, supporting the standalone development aim. Discovery cost is stated as $7.20 per gold-equivalent ounce.
March 2022 quarter: assays still pending on Minyari greenfields (6,440m), Citadel, Wilki and all IGO Paterson air core. A 2022 Minyari resource update is described as imminent, and Citadel's $10m CY22 field work restarts in April. Mostly known results; a Minyari East discovery is recapped.
Interim financial report for the half-year to 31 December 2021, with the board and auditor BDO unchanged. Visible text is the directory and operations review recapping known projects and partner farm-ins; no financial figures are visible in the text provided.
Final nine Minyari holes returned deep high-grade gold, including 98m at 1.41 g/t and 12.7m at 6.32 g/t, and a new WACA West discovery 150m west of WACA. All resource-drilling assays are in; 6,440m of greenfield assays remain pending. Management points to a resource increase next.
Fifty more Minyari and WACA holes returned high-grade gold, including 142m at 1.87 g/t and 35m at 3.52 g/t. Drilling for 2021 totals 52,750m, with assays for the final 11,200m pending. Extends mineralisation; no new resource figure yet.
December 2021 quarter: all four drilling programmes completed, with many assays still pending for Q1 2022. Cash about $11.9m (including $1.6m held for farm-in parties), down from $21.2m in September. Mostly recaps known Minyari, Citadel, Wilki and IGO results.
IGO has met its initial $4m Paterson commitment and elected to proceed, taking over management of the project from March 2022. It must now spend a further $26m by January 2027 to earn 70%, then free-carry Antipa to Feasibility Study.